🔗 Permalink

Assignee profile:

OP-T LLC

City:

Aurora, Colorado

Country:

United States

Published Applications:

7

Last publication date:

2024-04-11

Patent Grants:

7

Last grant date:

2025-11-18

Top Inventors for applications by OP-T LLC

These are the the leading inventors for applications assigned to OP-T LLC:

Charles W. HENRY 6 Denver, CO United States
David Hal Wagner, JR. 4 Denver, CO United States
Martin Glenn Yussman 4 Denver, CO United States
Gisela M. Vaitaitis 3 Centennial, CO United States

David H. Wagner Jr. 3 Denver, CO United States
Martin G. Yussman 2 Denver, CO United States
Charles W. Henry 1 Demver, CO United States
Martin G. Yussman 1 Denver, Colombia

David Wagner 1 Denver, CO United States

Recent patent applications by OP-T LLC

OP-T LLC based in Aurora, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-04-11 ✅ Patent 12,472,223 granted on 2025-11-18

US20240115651A1

Human necessities

PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS

#2 | 2023-03-30 ✅ Patent 12,226,450 granted on 2025-02-18

US20230101772A1

Human necessities

Peptides and methods for treating disease

#3 | 2022-04-07 ✅ Patent 12,649,775 granted on 2026-06-09

US20220106381A1

Chemistry; metallurgy

CD154 PEPTIDES AND METHODS OF INHIBITING CD40 INTERACTIONS WITH CD154

#4 | 2022-01-06 ✅ Patent 12,048,734 granted on 2024-07-30

US20220000979A1

Human necessities

Bioactive peptides and methods of use thereof

#5 | 2021-10-28 ✅ Patent 12,428,465 granted on 2025-09-30

US20210332104A1

Chemistry; metallurgy

THERAPEUTIC PEPTIDES AND METHODS FOR TREATING AUTOIMMUNE RELATED DISEASE

#6 | 2021-01-14 ✅ Patent 11,744,875 granted on 2023-09-05

US20210008162A1

Human necessities

Peptides and methods for treating disease

#7 | 2020-09-24 ✅ Patent 11,793,854 granted on 2023-10-24

US20200297795A1

Human necessities

Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction

Also check out OP-T LLC's (Aurora, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

603614 ⎘